TrialCancer gene therapy2003
A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.
Alok A Khorana et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papertrialcites it